Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

SYRESYRE
6 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in Spyre Therapeutics, Inc

Avoro Capital Advisors LLC previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$140,361

Total Shares Change

-11,458

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$22.54
0
2024-Q3
Decreased
598,600
-67.5%
$17.6M0.3%$28.49
0
2024-Q2
Unchanged
1.8M
0.0%
$43.2M0.6%$23.51
0
2024-Q1
Unchanged
1.8M
0.0%
$69.8M0.8%$37.93
0
2023-Q4
Increased
1.8M
+160x
$39.6M0.5%$21.52
67
2023-Q3
New
11,458
-
$140,3610.0%$12.25
32

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used